Abstract:

Objective

To explore the efficacy of respiratory rehabilitation in patients with bronchiectasis-related hemoptysis after bronchial artery embolization （BAE） treatment.

Methods

From January 2022 to July 2023， the clinical data of 25 patients with bronchiectasis-related hemoptysis who underwent success BAE treatment and followed receiving respiratory rehabilitation treatment at the First Affiliated Hospital with Nanjing Medical University were collected retrospectively.The cumulative recurrence-free rate of hemoptysis， degree of dyspnea at 6 months and health-realated quality of life were analyzed.The degree of dyspnea was evaluated by modified Medical Research Council dyspnea （mMRC）classification； and health-realated quality of life （HRQOL） was assessed by 12-item short-form health survey questionnaire （SF-12）.

Results

The median age of all patients was 60 years old and female accounted for 48%.The history of hemoptysis in 13 patients was more than 6 months.The degree of hemoptysis included mild in 14 patients （56%） and moderate in 11 cases （44%）.The cumulative recurrence-free rate of hemoptysis at 1， 3， and 6 months after procedure were 96%， 88% and 84%， respectively.The mMRC classification were 18 （72%） in grade 0， 6 （24%） in grade I， and 1 （4%） in grade III， respectively.Twenty-one （84%） patients had SF-12 score with PCS＞50， while 25 （100%） patients had MCS＞50.

Conclusion

Transarterial embolization was effective in treating bronchiectasis-related hemoptysis.Respiratory rehabilitation could improve the degree of dyspnea and quality of life for these patients.

Key words: Respiratory rehabilitation, Bronchiectasis, Hemoptysis, HRQOL, Bronchial artery embolization